Literature DB >> 20958856

A prospective randomized study of 980 nm diode laser-assisted venous ulcer healing on 34 patients.

Franck Marie Leclère1, Isabelle Renaud Puechguiral, Guy Rotteleur, Pierre Thomas, Serge R Mordon.   

Abstract

Venous ulcers are chronic wounds affecting up to 1% of adults in developed countries. Considering that noncontact normothermic therapy has been shown to modify the wound healing process, we conducted a prospective comparative clinical trial aimed at evaluating 980 nm diode laser in laser-assisted venous ulcer healing. Thirty-four Caucasian patients with venous leg ulcers were included in the study and separated into two homogenous groups based on age, sex ratio, size, and etiologies of the ulcers. In the laser group, 980 nm InGasAs diode laser (power 15 W, spot size 8 mm, time 3 seconds, fluence 90 J/cm(2) ) was applied weekly for 9 weeks to the ulcers in a homogenous standardized manner, resulting in a local temperature of 45-50 °C, which was controlled with a thermal infrared camera. Complete healing, reduction in size, and pain during and between each procedure were evaluated each time. Of the 18 patients in the laser group, three (16.7%) were completely healed during laser treatment. In the control group (16 patients), the healing was complete for four patients (25%). This difference was not significant (p=0.62). At the ninth follow-up visit, in the control group, the ulcers had decreased on an average to 94.3% of the original area of the ulcers. In the laser group, the decrease was to 74.2% of the original area of the ulcers. Again, this difference was not significant (p=0.60). The mean VAS score between each treatment was 2.7 (0.5-4.4) in the laser group compared with 3.8 (2.3-5.0) in the control group (0.13<p<0.86). During the treatment, the mean VAS score was 1.8 (0.2-3.8) in the laser group compared with 3.8 (2.1-6.0) in the control group (0.08<p<0.67). 980 nm diode laser-assisted venous ulcer healing was easy to perform and very well tolerated. However, there were no statistically significant differences in reduction of ulcer size between the two groups, suggesting that this particular laser regimen does not promote wound healing. Additional studies involving larger patient populations and an increased frequency of treatment should be performed to confirm our initial conclusions.
© 2010 by the Wound Healing Society.

Entities:  

Mesh:

Year:  2010        PMID: 20958856     DOI: 10.1111/j.1524-475X.2010.00637.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  6 in total

1.  Effects of weekly LED therapy at 625 nm on the treatment of chronic lower ulcers.

Authors:  Cláudia Patrícia Cardoso Martins Siqueira; Solange de Paula Ramos; Cynthia A A Gobbi; Leonardo Shigaki; Roberto K Kashimoto; Emerson José Venâncio; Dari de Oliveira Toginho Filho; André G Castaldin; Alan S Felinto; Francisco Pereira Silva; Ricardo B Silva; Ivan Frederico Lupiano Dias
Journal:  Lasers Med Sci       Date:  2014-10-15       Impact factor: 3.161

Review 2.  Venous leg ulcers.

Authors:  E Andrea Nelson
Journal:  BMJ Clin Evid       Date:  2011-12-21

3.  Effective use of negative pressure wound therapy provides quick wound-bed preparation and complete graft take in the management of chronic venous ulcers.

Authors:  Onur Egemen; Ozay Ozkaya; Muhammed Besir Ozturk; Tolga Aksan; Çağdaş Orman; Mithat Akan
Journal:  Int Wound J       Date:  2011-10-12       Impact factor: 3.315

Review 4.  Venous leg ulcers.

Authors:  E Andrea Nelson; Una Adderley
Journal:  BMJ Clin Evid       Date:  2016-01-15

5.  Abdominal wall reconstruction with Two-step Technique (TST): a prospective study in 20 patients.

Authors:  Marwan Al Zarouni; Mario A Trelles; Franck M Leclère
Journal:  Int Wound J       Date:  2013-06-20       Impact factor: 3.315

Review 6.  Low level laser therapy for the treatment of diabetic foot ulcers: a critical survey.

Authors:  Kathrin H Beckmann; Gesa Meyer-Hamme; Sven Schröder
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-16       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.